Vital innovations that bring the right care to everyone, everywhere
With our connected technology platform, we partner with health systems, risk-bearing organizations, and life science companies to revolutionize drug life cycle management and delivery of care across the continuum.
Learn more about our solutions
Vital innovations that bring the right care to everyone, everywhere
With our connected technology platform, we partner with health systems, risk-bearing organizations, and life science companies to revolutionize drug life cycle management and delivery of care across the continuum.
Learn more about our solutions
Connecting solutions to step up care
Biofourmis addresses challenges impacting the health and pharmaceutical industries today across the continuum from drug development to care delivery. By delivering and transitioning patients across levels of care, clinical trials, and drug companions, our solutions offer patients continuity of care and more care options. Our partners rely on Biofourmis for streamlined services, access to targeted patient populations, and improved economic, operational, and clinical outcomes.
.svg)
Expanding clinical trial access
.svg)
Addressing hospital capacity
.svg)
Solving staffing shortages
Optimizing medication management
.svg)
Advancing drug commercialization
Increasing patient engagement
.svg)
Managing chronic conditions
Expanding clinical trial access
Optimizing medication management
Advancing drug commercialization
Addressing hospital capacity
Solving staffing shortages
Managing chronic conditions
Increasing patient engagement
Addressing hospital capacity
Expanding clinical trial access
Solving staffing shortages
Optimizing medication management
Managing chronic conditions
Advancing drug commercialization
Increasing patient engagement
Making home the site of care
Our technology-enabled solutions empower patients to receive care at home, and easily transition between levels and locations of care. Outcomes have shown clinical, operational, and economic improvements such as a 70% reduction in 30-day readmissions, the ability to detect deterioration 21 hours sooner, and reductions in cost of care by up to 38%1,2.
.webp)
Managing the drug life cycle
We enable life science companies to deliver clinical trials anywhere, and to commercialize novel therapies and digital health products.*
Our collaborators in the healthcare-delivery revolution
News & Insights
1. Un, KC., Wong, CK., Lau, YM. et al. Observational study on wearable biosensors and machine learning-based remote monitoring of COVID-19 patients. Sci Rep 11, 4388 (2021). https://doi.org/10.1038/s41598-021-82771-7.
2. Levine DM, Ouchi K, Blanchfield B, Saenz A, Burke K, Paz M, Diamond K, Pu CT, Schnipper JL. Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial. Ann Intern Med. 2020 Jan 21;172(2):77-85. doi: 10.7326/M19-0600. Epub 2019 Dec 17. PMID: 31842232.
*Subject to geography and connectivity